530538 | cPLA2α Inhibitor II, Pyrrophenone - Calbiochem

530538
価格が見つかりません
Minimum Quantity needs to be mulitiple of
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      価格&在庫状況を照会
      クリックして印刷用に表示

      概要

      Replacement Information

      主要スペック表

      Empirical Formula
      C₄₉H₃₇F₂N₃O₅S₂

      価格&在庫状況

      カタログ番号在庫状況 包装 Qty/Pk 価格 数量
      5.30538.0001
      在庫状況検索中…
      現在国内在庫なし現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください

          ガラスビン 1 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          Description
          OverviewA cell-permeable, non-toxic, pyrolidine derivative that acts as a highly potent, and reversible inhibitor of cytosolic phospholipase A2a (cPLA2a; IC50 = 4.2 nM). Does not inhibit the activities of PLA IB and IIA groups even at higher concentrations (~250 µM). Unlike AACOCF3 (Cat. No. 100109), its action is shown to be rapid and does not require a pre-incubation period. Diminishes the release of arachidonic acid (IC50 = 24 nM), prostaglandin E2 (PGE2; IC50 = 25 nM) and leukotriene C4 (IC50 = 14 nM) in A23187 stimulated THP-1 cells. Its effects on production of PGE2 and thromboxane B2 are comparable to those of indomethacin. Also shown to inhibit the lysophospholipase and esterase activity of cPLA2&alpha.

          Please note that the molecular weight for this compound is batch-specific due to variable water content.
          Catalogue Number530538
          Brand Family Calbiochem®
          SynonymsPhospholipase A2α Inhibitor
          References
          ReferencesOno, T., et al. 2002. Biochem. J. 363, 727.
          Seno, K., et al. 2001. Bioorg. Med. Chem. Lett. 11, 587.
          Product Information
          FormOff-white powder
          Hill FormulaC₄₉H₃₇F₂N₃O₅S₂
          Chemical formulaC₄₉H₃₇F₂N₃O₅S₂
          Applications
          Biological Information
          Primary TargetPLA2a
          Primary Target IC<sub>50</sub>4.2 nM
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
          Toxicity Standard Handling
          Storage -20°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          (M)SDS

          タイトル

          英語版製品安全データシート((M)SDS) 

          参考資料

          参考資料の概要
          Ono, T., et al. 2002. Biochem. J. 363, 727.
          Seno, K., et al. 2001. Bioorg. Med. Chem. Lett. 11, 587.

          カタログ

          タイトル
          NPI Flyer- Epigenetics and Nuclear Function Feature
          New Products - Antibodies, Small Molecule, Inhibitors (MM)

          技術情報

          タイトル
          White Paper: Further considerations of antibody validation and usage.
          データシート

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision31-October-2014 JSW
          SynonymsPhospholipase A2α Inhibitor
          DescriptionA cell-permeable, non-toxic, pyrolidine derivative that acts as a highly potent, and reversible inhibitor of cytosolic phospholipase A2a (cPLA2a; IC50 = 4.2 nM). Does not inhibit the activities of PLA IB and IIA groups even at higher concentrations (~250 µM). Unlike AACOCF3 (Cat. No. 100109), its action is shown to be rapid and does not require a pre-incubation period. Diminishes the release of arachidonic acid (IC50 = 24 nM), prostaglandin E2 (PGE2; IC50 = 25 nM) and leukotriene C4 (IC50 = 14 nM) in A23187 stimulated THP-1 cells. Its effects on production of PGE2 and thromboxane B2 are comparable to those of indomethacin. Also shown to inhibit the lysophospholipase and esterase activity of cPLA2&alpha.
          FormOff-white powder
          Intert gas (Yes/No) Packaged under inert gas
          Chemical formulaC₄₉H₃₇F₂N₃O₅S₂
          Purity≥98% by HPLC
          SolubilityDMSO (100 mg/ml)
          Storage -20°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Standard Handling
          ReferencesOno, T., et al. 2002. Biochem. J. 363, 727.
          Seno, K., et al. 2001. Bioorg. Med. Chem. Lett. 11, 587.